Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Long-Term Investments (2020 - 2022)

NovaBridge Biosciences (NBP) has disclosed Long-Term Investments for 3 consecutive years, with $4.3 million as the latest value for Q4 2022.

  • Quarterly Long-Term Investments fell 92.12% to $4.3 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2022, down 92.12% year-over-year, with the annual reading at $4.5 million for FY2022, 91.9% down from the prior year.
  • Long-Term Investments for Q4 2022 was $4.3 million at NovaBridge Biosciences, down from $55.1 million in the prior quarter.
  • The five-year high for Long-Term Investments was $55.1 million in Q4 2021, with the low at -$13.0 million in Q4 2020.
  • Average Long-Term Investments over 3 years is $15.5 million, with a median of $4.3 million recorded in 2022.
  • The sharpest move saw Long-Term Investments surged 524.66% in 2021, then tumbled 92.12% in 2022.
  • Over 3 years, Long-Term Investments stood at -$13.0 million in 2020, then soared by 524.66% to $55.1 million in 2021, then crashed by 92.12% to $4.3 million in 2022.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $4.3 million, $55.1 million, and -$13.0 million for Q4 2022, Q4 2021, and Q4 2020 respectively.